911 — Qianhai Health Holdings Income Statement
0.000.00%
- HK$45.75m
- -HK$15.21m
- HK$677.12m
Annual income statement for Qianhai Health Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 283 | 1,962 | 961 | 520 | 677 |
| Cost of Revenue | |||||
| Gross Profit | 4.62 | -162 | -35.6 | 29.7 | 23.6 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 284 | 2,195 | 1,014 | 518 | 671 |
| Operating Profit | -0.38 | -234 | -52.7 | 1.33 | 5.98 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.888 | -234 | -52.7 | 1.31 | 5.94 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.888 | -234 | -52.7 | 1.31 | 5.94 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.888 | -234 | -52.7 | 1.31 | 5.94 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.888 | -234 | -52.7 | 1.31 | 5.94 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.09 | -1.51 | -0.311 | -0.274 | 0.043 |